80 Association of in situ T-cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma (HNSCC)
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797629664258162688 |
|---|---|
| author | Matthew Loya Homer Adams Omar Jabado Patrick Franken Nora Pencheva Mark Fereshteh Li Fan Anantharaman Muthuswamy Angelo Harris Susan Sun Gabrielle Suppa |
| author_facet | Matthew Loya Homer Adams Omar Jabado Patrick Franken Nora Pencheva Mark Fereshteh Li Fan Anantharaman Muthuswamy Angelo Harris Susan Sun Gabrielle Suppa |
| author_sort | Matthew Loya |
| collection | DOAJ |
| first_indexed | 2024-03-11T10:57:19Z |
| format | Article |
| id | doaj.art-7403e914b9eb4aa7beb2906baa405205 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T10:57:19Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-7403e914b9eb4aa7beb2906baa4052052023-11-13T06:10:06ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.008080 Association of in situ T-cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma (HNSCC)Matthew Loya0Homer Adams1Omar Jabado2Patrick Franken3Nora Pencheva4Mark Fereshteh5Li Fan6Anantharaman Muthuswamy7Angelo Harris8Susan Sun9Gabrielle Suppa101Genmab, Princeton, NJ, USAAff565 Janssen Pharmaceutical R&D Spring House PA USA1 Translational Bioinformatics, Bristol-Myers Squibb, Princeton, New Jersey, USAGenmab, Princeton, NJ, USA3Genmab, Utrecht, Netherlands2Genmab A/S, Utrecht, NetherlandsGenmab, Princeton, NJ, USAGenmab, Plainsboro, NJ, USAGenmab, Princeton, NJ, USA1Genmab, Princeton, NJ, USA1Genmab US, Inc., Princeton, NJ, USA |
| spellingShingle | Matthew Loya Homer Adams Omar Jabado Patrick Franken Nora Pencheva Mark Fereshteh Li Fan Anantharaman Muthuswamy Angelo Harris Susan Sun Gabrielle Suppa 80 Association of in situ T-cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma (HNSCC) Journal for ImmunoTherapy of Cancer |
| title | 80 Association of in situ T-cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma (HNSCC) |
| title_full | 80 Association of in situ T-cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma (HNSCC) |
| title_fullStr | 80 Association of in situ T-cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma (HNSCC) |
| title_full_unstemmed | 80 Association of in situ T-cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma (HNSCC) |
| title_short | 80 Association of in situ T-cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma (HNSCC) |
| title_sort | 80 association of in situ t cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma hnscc |
| work_keys_str_mv | AT matthewloya 80associationofinsitutcellreceptordiversityandtumoradjacentimmunecellstocheckpointinhibitorresponseinheadandnecksquamouscellcarcinomahnscc AT homeradams 80associationofinsitutcellreceptordiversityandtumoradjacentimmunecellstocheckpointinhibitorresponseinheadandnecksquamouscellcarcinomahnscc AT omarjabado 80associationofinsitutcellreceptordiversityandtumoradjacentimmunecellstocheckpointinhibitorresponseinheadandnecksquamouscellcarcinomahnscc AT patrickfranken 80associationofinsitutcellreceptordiversityandtumoradjacentimmunecellstocheckpointinhibitorresponseinheadandnecksquamouscellcarcinomahnscc AT norapencheva 80associationofinsitutcellreceptordiversityandtumoradjacentimmunecellstocheckpointinhibitorresponseinheadandnecksquamouscellcarcinomahnscc AT markfereshteh 80associationofinsitutcellreceptordiversityandtumoradjacentimmunecellstocheckpointinhibitorresponseinheadandnecksquamouscellcarcinomahnscc AT lifan 80associationofinsitutcellreceptordiversityandtumoradjacentimmunecellstocheckpointinhibitorresponseinheadandnecksquamouscellcarcinomahnscc AT anantharamanmuthuswamy 80associationofinsitutcellreceptordiversityandtumoradjacentimmunecellstocheckpointinhibitorresponseinheadandnecksquamouscellcarcinomahnscc AT angeloharris 80associationofinsitutcellreceptordiversityandtumoradjacentimmunecellstocheckpointinhibitorresponseinheadandnecksquamouscellcarcinomahnscc AT susansun 80associationofinsitutcellreceptordiversityandtumoradjacentimmunecellstocheckpointinhibitorresponseinheadandnecksquamouscellcarcinomahnscc AT gabriellesuppa 80associationofinsitutcellreceptordiversityandtumoradjacentimmunecellstocheckpointinhibitorresponseinheadandnecksquamouscellcarcinomahnscc |